Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia

Neurology

Volumn 63, Issue 2, 2004, Pages 220-227

  DeCarli, C ^a,b,d   Mungas, D ^a   Harvey, D ^b   Reed, B ^a   Weiner, M ^c   Chui, H ^a   Jagust, W ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN SIZE; CEREBROVASCULAR DISEASE; CLINICAL DEMENTIA RATING SCALE; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RATING SCALE; SURVIVAL RATE; TASK PERFORMANCE;

EID: 3242784764     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000130531.90205.EF     Document Type: Article

References (60)

1. Cutler SJ, Grams AE. Correlates of self-reported everyday memory problems. J Gerontol Soc Sci 1988;43:S82-S90.
2. O'Connor DW, Pollitt PA, Roth M, Brook PB, Reiss BB. Memory complaints and impairment in normal, depressed and demented elderly persons identified in a community survey. Arch Gen Psychiatry 1990; 47:224-227.
3. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001;17:101-118.
4. Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999;45:358-368.
5. Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
6. Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303-308.
7. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985-1992.
8. Graham JE, Rockwood K, Beattie BL, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;349:1793-1796.
9. Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment. A population-based validation study. Neurology 2001;56: 37-42.
10. DeCarli C. Defining mild cognitive impairment: prevalence, prognosis, etiology and treatment. Lancet Neurol 2003;2:15-21.
11. DeCarli C, Miller BL, Swan GE, et al. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643-647.
12. Lopez OL, Jagust WJ, Dulberg C, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study: part 2. Arch Neurol 2003;60:1394-1399.
13. Launer LJ, Masaki K, Petrovich H, Foley D, Havlik RJ. The association between mid-life blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA 1995;274:1846-1851.
14. DeCarli C, Murphy DG, Tranh M, et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995;45:2077-2084.
15. Swan GE, DeCarli C, Miller BL, et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998;51:986-993.
16. Swan GE, DeCarli C, Miller BL, et al. Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy. Neurology 2000;54:2108-2114.
17. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 2002;51:567-577.
18. Fein G, Di Sclafani V, Tanabe J, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000;55:1626-1635.
19. Mungas D, Reed B, Ellis WG, Jagust WJ. The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 2001;58:1243-1247.
20. Vermeer SE, Prins ND, den Heijer T, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222.
21. Mungas D, Jagust WJ, Reed BR, et al. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001;57:2229-2235.
22. Rockwood K, Wentzel C, Hachinski V, et al. Prevalence and outcomes of vascular cognitive impairment. Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000;54: 447-451.
23. Berg L, Hughes CP, Coben LA, et al. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J Neurol Neurosurg Psychiatry 1982;45:962-968.
24. Morris JC, McKeel DW, Fulling K, Torack RM, Berg L. Validation of clinical diagnostic criteria for Alzheimer's disease. Ann Neurol 1988;24: 17-22.
25. Hambleton RK, Swaminathan H. Item response theory. Principles and applications. Boston: Kluwer-Nijhoff, 1985.
26. Mungas D, Reed BR, Kramer JH. Psychometrically matched measures of global cognition, memory, and executive function for assessment of cognitive decline in older persons. Neuropsychology 2003;17:380-392.
27. Williams J. Memory Assessment Scales. Odessa: Psychological Assessment Resources, 1991.
28. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio: Psychological Corp., 1981.
29. Benton AL, Hamsher K. Multilingual Aphasia Examination. Iowa City: University of Iowa, 1976.
30. Mattis S. Dementia Rating Scale. Odessa, FL: Psychological Assessment Resources, 1988.
31. Haller JW, Christensen GE, Joshi SC, et al. Hippocampal MR imaging morphometry by means of general pattern matching. Radiology 1996; 199:787-791.
32. Haller JW, Banerjee A, Christensen GE, et al. Three-dimensional hippocampal MR morphometry with high-dimensional transformation of a neuroanatomic atlas. Radiology 1997;202:504-510.
33. Wu CC, Mungas D, Petkov CI, et al. Brain structure and cognition in a community sample of elderly Latinos. Neurology 2002;59:383-391.
34. Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 2001;58:411-416.
35. Slooter AJ, van Duijn CM, Bots ML, et al. Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study. J Neural Transm (Suppl) 1998;53:17-29.
36. Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2000;21: 49-55.
37. Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996;347:1141-1145.
38. Kivipelto M, Helkala EL, Hanninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683-1689.
39. Kivipelto M, Helkala EL, Laakso MP, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. Br Med J 2001;322:1447-1451.
40. Kivipelto M, Laakso MP, Tuomilehto J, Nissinen A, Soininen H. Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention. CNS Drugs 2002;16: 435-444.
41. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry 2000;15:803-812.
42. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci 1986;13(suppl 4):5533-5534.
43. Lopez OL, Becker JT, Jungreis CA, et al. Computed tomography-but not magnetic resonance imaging-identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol 1995;52:659-664.
44. Boone KB, Miller BL, Lesser IM, Mehringer CM, Hill E, Berman N. Cognitive deficits with white-matter lesions in healthy elderly Arch Neurol 1992;49:549-554.
45. Marquis S, Moore MM, Howieson DB, et al. Independent predictors of cognitive decline in healthy elderly persons. Arch Neurol 2002;59:601-606.
46. Visser PJ, Scheltens P, Verhey FR, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 1999;246:477-485.
47. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-1403.
48. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann NY Acad Sci 1996;802:58-69.
49. Tierney MC. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 2001;57: 163-164.
50. Kaye JA, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology 1997;48:1297-1304.
51. Fox NC, Warrington EK, Stevens JM, Rossor MN. Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation. Ann NY Acad Sci 1996;777: 226-232.
52. de Leon M, George A, Convit A, et al. The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14:897-906.
53. Tierney MC, Szalai JP, Snow WG, et al. A prospective study of the clinical utility of ApoE genotype in the prediction of outcome in patients with memory impairment. Neurology 1996;46:149-154.
54. Tabert MH, Albert SM, Borukhova-Milov L, et al. Functional deficits in patients with mild cognitive impairment: prediction of AD. Neurology 2002;58:758-764.
55. Albert SM, Tabert MH, Dienstag A, Pelton G, Devanand E. The impact of mild cognitive impairment on functional abilities in the elderly. Curr Psychiatry Rep 2002;4:64-68.
56. Jack CR, Dickson DW, Parisi JE, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-757.
57. Petersen RC, Jack CR Jr, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000;54:581-587.
58. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794.
59. Reed BR, Eberling JL, Mungas D, Weiner MW, Jagust WJ. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol 2000;48:275-284.
60. Kramer JH, Reed BR, Mungas D, Weiner MW, Chui HC. Executive dysfunction in subcortical ischaemic vascular disease. J Neurol Neurosurg Psychiatry 2002;72:217-220.